Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06091319 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Florbetaben for Imaging of Vascular Amyloid

Study acronym: FERMATA
StatusRecruiting
PhaseNot specified
Started2023-10-09
View on ClinicalTrials.gov ↗
The Primary Objective is to determine if a new nuclear tracer (named 18F-Florbetaben) used with nuclear imaging (PET imaging) can detect inflamed plaque in patients with recent ACS or stroke/TIA.

Amendment history 2 changes detected by DataLookout

2026-09-09
Primary completion pushed: 2026-08-01 → 2026-12-01
2026-09-09
Completion pushed: 2026-08-01 → 2026-12-01
Trial Details
NCT Number NCT06091319
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions Acute Coronary Syndrome, Stroke, Transient Ischemic Attack, Atherosclerosis of Artery
Enrollment 30 participants
Start Date 2023-10-09
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-08